1Yogev Y, Langer O. The use of anti - hyperglycaemic and hypoglycaemic agents in pregnancy. Fetal Matern Med Rev,2004,15 : 133 - 143
2Hellmuth E, Datum P, Molsted - Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med,2000,17:507 - 11
3Koren G. Glyburide and fetal safety; t ransplacental pharmaco2 kinetic considerations. Reprod Toxieol, 2001, 15 : 2272 - 2291
4Langer O, Conway DL, Berkus MD, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000 ;343 : 1134 -8
5Jakubowicz D J, Iuorno M J, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002 ;87:524 - 9
6Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitu- dinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod,2004,19:510-521
7Glueck C J, Goldenberg N, Pranikoff J, et al. Height, weight, and motor - social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004 ; 19 : 1323 - 30
8Glueck C J, Bornovali S, Pranikoff J, et al. Metformin, pre - eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med, 2004 ;21:829 - 36
9Zarate A, Oehoa R, Hernandez M, Basurto L. Effectiveness of acarbose in the control of glucose tolerance worsening in pregnancy. Ginecol Obstet Mex ,2000,68:42 - 5
10Francis LW Ho, Choon - Fong Liew, Elaine C Cunanan, Kok - Onn Lee. Oral hypoglycaemic agents for diabetes in pregnancy - an appraisal of the current evidence for oral anti - diabetic drug use in pregnancy. Ann Acad Med Singapore. Ann Acad Med Singapore,2007, 36,672 -678
